Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection

Abstract Introduction Previous studies have described some risk factors for multidrug-resistant (MDR) bacteria in urinary tract infection (UTI). However, the clinical impact of MDR bacteria on older hospitalized patients with community-acquired UTI has not been broadly analyzed. We conducted a study...

Full description

Bibliographic Details
Main Authors: Manuel Madrazo, Ana Esparcia, Ian López-Cruz, Juan Alberola, Laura Piles, Alba Viana, José María Eiros, Arturo Artero
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-021-06939-2
_version_ 1818701160910946304
author Manuel Madrazo
Ana Esparcia
Ian López-Cruz
Juan Alberola
Laura Piles
Alba Viana
José María Eiros
Arturo Artero
author_facet Manuel Madrazo
Ana Esparcia
Ian López-Cruz
Juan Alberola
Laura Piles
Alba Viana
José María Eiros
Arturo Artero
author_sort Manuel Madrazo
collection DOAJ
description Abstract Introduction Previous studies have described some risk factors for multidrug-resistant (MDR) bacteria in urinary tract infection (UTI). However, the clinical impact of MDR bacteria on older hospitalized patients with community-acquired UTI has not been broadly analyzed. We conducted a study in older adults with community-acquired UTI in order to identify risk factors for MDR bacteria and to know their clinical impact. Methods Cohort prospective observational study of patients of 65 years or older, consecutively admitted to a university hospital, diagnosed with community-acquired UTI. We compared epidemiological and clinical variables and outcomes, from UTI due to MDR and non-MDR bacteria. Independent risk factors for MDR bacteria were analyzed using logistic regression. Results 348 patients were included, 41.4% of them with UTI due to MDR bacteria. Median age was 81 years. Hospital mortality was 8.6%, with no difference between the MDR and non-MDR bacteria groups. Median length of stay was 5 [4–8] days, with a longer stay in the MDR group (6 [4–8] vs. 5 [4–7] days, p = 0.029). Inadequate empirical antimicrobial therapy (IEAT) was 23.3%, with statistically significant differences between groups (33.3% vs. 16.2%, p < 0.001). Healthcare-associated UTI variables, in particular previous antimicrobial therapy and residence in a nursing home, were found to be independent risk factors for MDR bacteria. Conclusions The clinical impact of MDR bacteria was moderate. MDR bacteria cases had higher IEAT and longer hospital stay, although mortality was not higher. Previous antimicrobial therapy and residence in a nursing home were independent risk factors for MDR bacteria.
first_indexed 2024-12-17T15:16:26Z
format Article
id doaj.art-c847b586d9264e2597cb0ab3884aacc0
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-17T15:16:26Z
publishDate 2021-12-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-c847b586d9264e2597cb0ab3884aacc02022-12-21T21:43:31ZengBMCBMC Infectious Diseases1471-23342021-12-012111710.1186/s12879-021-06939-2Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infectionManuel Madrazo0Ana Esparcia1Ian López-Cruz2Juan Alberola3Laura Piles4Alba Viana5José María Eiros6Arturo Artero7Internal Medicine Department, Doctor Peset University HospitalInternal Medicine Department, Doctor Peset University HospitalInternal Medicine Department, Doctor Peset University HospitalMicrobiology Department, Doctor Peset University HospitalInternal Medicine Department, Doctor Peset University HospitalInternal Medicine Department, Doctor Peset University HospitalDepartment of Microbiology and Parasitology, Rio Hortega University Hospital, University of ValladolidInternal Medicine Department, Doctor Peset University HospitalAbstract Introduction Previous studies have described some risk factors for multidrug-resistant (MDR) bacteria in urinary tract infection (UTI). However, the clinical impact of MDR bacteria on older hospitalized patients with community-acquired UTI has not been broadly analyzed. We conducted a study in older adults with community-acquired UTI in order to identify risk factors for MDR bacteria and to know their clinical impact. Methods Cohort prospective observational study of patients of 65 years or older, consecutively admitted to a university hospital, diagnosed with community-acquired UTI. We compared epidemiological and clinical variables and outcomes, from UTI due to MDR and non-MDR bacteria. Independent risk factors for MDR bacteria were analyzed using logistic regression. Results 348 patients were included, 41.4% of them with UTI due to MDR bacteria. Median age was 81 years. Hospital mortality was 8.6%, with no difference between the MDR and non-MDR bacteria groups. Median length of stay was 5 [4–8] days, with a longer stay in the MDR group (6 [4–8] vs. 5 [4–7] days, p = 0.029). Inadequate empirical antimicrobial therapy (IEAT) was 23.3%, with statistically significant differences between groups (33.3% vs. 16.2%, p < 0.001). Healthcare-associated UTI variables, in particular previous antimicrobial therapy and residence in a nursing home, were found to be independent risk factors for MDR bacteria. Conclusions The clinical impact of MDR bacteria was moderate. MDR bacteria cases had higher IEAT and longer hospital stay, although mortality was not higher. Previous antimicrobial therapy and residence in a nursing home were independent risk factors for MDR bacteria.https://doi.org/10.1186/s12879-021-06939-2Older adultsRisk factorInadequate empirical antimicrobial therapyOutcomes
spellingShingle Manuel Madrazo
Ana Esparcia
Ian López-Cruz
Juan Alberola
Laura Piles
Alba Viana
José María Eiros
Arturo Artero
Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
BMC Infectious Diseases
Older adults
Risk factor
Inadequate empirical antimicrobial therapy
Outcomes
title Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
title_full Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
title_fullStr Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
title_full_unstemmed Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
title_short Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection
title_sort clinical impact of multidrug resistant bacteria in older hospitalized patients with community acquired urinary tract infection
topic Older adults
Risk factor
Inadequate empirical antimicrobial therapy
Outcomes
url https://doi.org/10.1186/s12879-021-06939-2
work_keys_str_mv AT manuelmadrazo clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT anaesparcia clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT ianlopezcruz clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT juanalberola clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT laurapiles clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT albaviana clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT josemariaeiros clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection
AT arturoartero clinicalimpactofmultidrugresistantbacteriainolderhospitalizedpatientswithcommunityacquiredurinarytractinfection